Psychopharmacotherapy in Multiple Substances Abuse
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Add-on of memantine or placebo treatment will proceed in a double-blinded fashion for 12
weeks after adjusted methadone dose. During the study, the investigators will evaluate
treatment response and adverse effect from multiple dimensions to elucidate the therapeutic
effect of add-on memantine on addictive behaviors. It will also explore the possible
advantage of this treatment on social re-adaptation and psychopathogenesis of opioid
dependence.